Reynolds, J
Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study
GLP-1 receptor agonists are pharmaceuticals that imitate the actions of glucagon-like peptide-1 hormones, which control blood glucose levels, slow down digestion in the stomach, and induce feelings of fullness, greatly affecting dietary habits and total caloric consumption

The GLP-1 RA and Its Relationship with Brain Insulin Resistance Brain IR can be defined as the failure of brain cells to respond to insulin, and the lack of response may be due to the downregulation of insulin receptors, an inability of insulin receptors to bind insulin, or faulty activation of the insulin signaling cascade.16 Insulin receptors are distributed throughout the brain, but have the highest concentration in the olfactory bulb, cerebral cortex, hypothalamus, hippocampus, and cerebellum.17 Insulin binds to the insulin receptor, phosphorylates the insulin receptor substrate (IRS), activates the phosphoinositide-3 kinase (PI3K) and mitogen-activated kinase (MAPK) pathways, and modifies the activity of several downstream effectors